ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 627695 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 627695; 2) Community: the network communities that were significantly associated with the response to NSC 627695; 3) Molecule: the relationships between components within communities and NSC 627695; 4) MDR: the compounds that were significantly associated with the NSC 627695.

NSC Compound Enrichment Correlation
NSC 709440 Null 0.00415749398947839 -0.0089645446
NSC 728035 1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di 0.00415749398947839 0.20701184
NSC 269720 Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- 0.0041872854493286 -0.048062015
NSC 359239 Antibiotic X-14766A 0.0041872854493286 -0.022154208
NSC 643836 Null 0.0041872854493286 -0.22334128
NSC 666138 Null 0.0041872854493286 0.0026254096
NSC 753188 4-chloro-N-(4-(3-(4-chloro-3-hydroxyphenyl)-4-(pyridin-4-yl)-1H-pyrazol-1-yl)phenyl)-3-(trifluoromethyl)benzamide 0.0041872854493286 0.39378284
NSC 620674 Null 0.00587884296262138 -0.22016985
NSC 630703 Acridomide 0.00587884296262138 0.055275299
NSC 643851 Null 0.00587884296262138 0.014059499
Total:42  Current:3    [First] [Prev] [Next] [Last]